The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score -10.17 — distress zone — historically elevated failure riskWatch
- Earnings-manipulation signal · Beneish M -6.28 — no flag raisedOK
- Earnings quality 88/100 — accruals in line with cashOK
Where the revenue comes from
Fiscal 2025, as HARVARD BIOSCIENCE INC reports it. History and quarterly detail are in the app.
- Instruments, Equipment, Software, and Accessories$78.3M
- Service, Maintenance, and Warranty Contracts$8.3M
Leadership changes
From HARVARD BIOSCIENCE INC's own filings, the day they're filed.
- Mark Frost · Chief Financial Officer · appointmenteff. 2026-03-06
- Stephen DeNelsky · director · appointmenteff. 2025-09-05
- John Duke · President · appointmenteff. 2025-07-28
Latest filings
- 10-Q · Quarterly report2026-08-11
- 8-K · Company announcement2026-08-11
- 8-K · Company announcement2026-08-11
- 8-K · Company announcement2026-06-02
- 8-K · Company announcement2026-05-12
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about HARVARD BIOSCIENCE INC, every answer cited to the official filings🔒
- The Intelligence Brief — added when HARVARD BIOSCIENCE INC's brief passes our SEC-figure check🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.